Hacking Cancer Together

We dream big. We imagine a world where cancer is curable.

The Latest at the Parker Institute

AACR19 WHATSNEW Post
Press Releases

Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019

March 20, 2019
IWD2019 WHATSNEW Post
Meet the Scientist

From Bench to Bedside: Dr. Padmanee Sharma Talks Biomarkers, Broken Arms and Being the Nobelle of the Ball

March 8, 2019
JB6 UCSF
Announcements

PICI President and CEO Jeffrey Bluestone To Be Honored with the AACR-Irving Weinstein Foundation Distinguished Lectureship

February 28, 2019
More

 The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.

World-renowned experts from leading cancer centers are at the forefront of our research.

Memorial Sloan Kettering Cancer Center
Stanford Medicine
UCLA
UCSF
Penn Medicine
MD Anderson Cancer Center
Fred Hutch Logo White
Isb Logo White
About Our Model
Parker Institute Parker Institute @parkerici We’re excited to share promising #pancreaticcancer trial results 📉 for #immunotherapy combined with standard-of-car… https://t.co/7T7WzcbDta 1 day ago
Parker Institute Parker Institute @parkerici ICYMI Jeff Bluestone, PhD, Parker Institute’s president and CEO, will be honored with the AACR-Irving Weinstein Fou… https://t.co/ts5n7t9lXU 2 days ago
Parker Institute Parker Institute @parkerici RT @CancerResearch: Can a richer fiber diet boost #immunotherapy response for melanoma patients? Dr. Christine Spencer of @parkerici shares… 3 days ago

Research Projects

Our investigators collaborate on high-risk, high-reward research projects

Our Partners

Working together to get much needed treatments to patients faster

For Patients

Furthering research to get treatments to patients faster

Our Model

A new approach to accelerate cancer breakthroughs

© 2019 All Rights Reserved
Member Center Login

Get Email Updates